Table 1.
Antimicrobial susceptibility testing of the three Myroides isolates
| TIC | PRL | TIM | TPZ | CAZ | FEP | CTX | ETP | MEM | IPM | TOB | AMK | GEN | CIP | ATM | RA | SXT | CT | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MO_32 | R | R | R | R | R | R | R | R | R | R | R | R | R | I | R | S | S | R |
| MO_35a | R | R | R | R | R | R | R | R | R | R | R | R | R | I | R | S | S | R |
| MO_104b | R | R | R | R | R | R | R | R | R | R | R | R | R | I | R | S | S | R |
MO, Myroides odoratimimus; TIC, ticarcillin; PRL, piperacillin; TIM, ticarcillin-clavulanic acid; TPZ, piperacillin-Tazobactam; CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; ETP, ertapenem; MEM, meropenem; IPM, imipenem; TOB, tobramycin; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; ATM, aztreonam; RA, rifampicin; SXT, sulfamethoxazole-trimethroprim; CT, colistin; R, resistant; I, intermediate; S, susceptible.